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Introduction
Charcot-Marie-Tooth disease (CMT) is the most common inherited neurologic disorder, affects 1 in 2,500 people worldwide. CMT includes three subtypes with autosomal dominant (CMT1, CMT2), recessive, and X-linked forms. The frequency of CMT in Japan is reported to be 10.8 cases per 100,000 populations [1] . The Xlinked form (CMTX) is found in about 10-20% of patients with hereditary demyelinating neuropathies. CMTX is characterized by slowly progressive distal muscle weakness and atrophy of the muscles resulting in characteristic steppage gait with pes cavus deformity, decreased deep tendon reflexes with sensory loss. In CMTX, males tend to be more severely affected than females due to X-linked recessive disorders. Female carriers are usually clinically asymptomatic but in some cases have developed severe symptoms with late onset. Sporadic case of X-linked CMT has also been identified [2] .
The X-linked form is associated with mutations in the gap junction protein β1 genes (GJB1) on chromosome Xq13.1. GJB1 is a gap junction protein expressed in various cells including oligodendrocytes and astrocytes and in tissues such as liver, brain and pancreas [3] . GJB1 has two extracellular loops, one intracellular loop, two intracellular terminal domains and four transmembrane segments. GJB1 proteins maintain the permeability of the neuron. Over 250 different mutations of the GJB1 genes have been identified [4] .
Here, we describe clinical and genetic analyses in a female patient with CMTX neuropathy who exhibited a mutation in the GJB1 gene as well as atypical scatted lesions in cerebral white matter of brain in T2-weighted magnetic resonance images (MRI).
Case report
A 41 year old woman presented with gait instability due to weakness of the lower limbs that appeared at the age of 21. At age 30, she noticed that slippers on the right foot came off and that the condition was worsening. At age 38, she noticed increasing weakness in the lower limbs. At age 39, she started to complain of progressive numbness in the distal arms and in the calf muscles. At age 40, she felt coldness in Laboratory studies for complete blood count, electrolytes, renal function, liver function, and vitamin B 12 and folate levels were normal. Cerebrospinal fluid, urine analysis and electrocardiogram showed no significant abnormalities. (Table 1) revealed that motor nerve conduction velocity (MNCV) and compound muscle action potential (CMAP) amplitude in the median nerve were reduced with prolonged distal latencies. Sensory conduction velocity (SNCV) and sensory nerve action potential (SNAP) amplitude were also reduced. In ulnar nerve, although distal latency and CMAP were normal, MNCV and SNCV were reduced. MNCVs were more affected in the tibial and peroneal nerves than in the median and ulnar nerves with reduced CMAP amplitudes. Temporal dispersion was observed in median and tibial nerves. SNAPs in sural nerve and F responses in median, ulnar, tibial and peroneal nerves were mostly absent.
Electrophysiological examination
Electromyography (EMG) of the anterior tibial muscle showed signs of chronic reinnervation changes with polyphagic motor unit potentials. This finding suggested that she had the features of both demyelinating polyneuropathy and axonopathy.
Electroencephalography, central conduction time in somatosentory evoked potentials (SEP) and auditory brainstem responses (ABR) were within normal limits. Brain MRI scans revealed atypical small scattered lesions were present in cerebral white matter in T2-and FLAIR-weighted images (Fig. 2 ). Brain and cervical MR angiographies were normal. Six months later, theses abnormal signals in brain MRI did not change. The origins of these abnormal intensities were unclear.
Informed consent was obtained from the patient and a blood sample was taken for molecular genetic studies. The Hokkaido University Ethics Committee approved this study. Genomic DNA was extracted using standard procedures. The coding exon2 of GJB1 was amplified by the polymerase chain reaction (PCR) using previously described primers [5] , and the amplified PCR product was sequenced directly using the BigDye Terminator Cycle Sequencing Kit (PE Applied Biosystems, Tokyo, Japan).
Genetic analysis of our case revealed a point mutation in exon 2 of the GJB1 gene resulting in the replacement of an arginine by a trytophan at position 142 of the translated protein (Arg142Trp). This mutation was previously reported in CMTX patients [3] .
Based on the results of this genetic analysis, together with a positive family history without male to male transmission, and the clinical features of slowed nerve conduction velocity and peripheral weakness with atrophy of the legs, the patient was diagnosed with CMTX.
Discussion
Among all CMT disorders, the frequency of CMTX is 20% in Japan. Overall 7.1% of CMTX patients show CNS involvement [6~9]. Six male patients with CMTX have been described with transient CNS symptoms and symmetrical white matter lesions that later resolved [6] [7] [8] . Recently one male patient with CMTX was described with permanent MRI signal abnormalities at the level of the corticospinal tract [9] . It is possible that GJB1 mutations might lead to white matter abnormalities and CNS symptoms due to chronic demyelination because GJB1 is expressed in oligodendrocytes [9] . Although MRI signal abnormalities in our case were maintained and subclinical through six months, further observation will be needed.
Many reports document clinically severely affected CMTX female patients without white matter lesion involvement [4, 8, 10, 11] . Here we have reported for the first time a female patient with atypical scattered lesions in cerebral white matter who exhibited all the clinical criteria of CMTX and had a mutation in the GJB1 gene. Previously, CMTX patients were reported with white matter lesions in the periventricular area, the parietal white matter, and in the splenium of corpus callosum [6] [7] [8] . Among them, only one male case showed scattered white matter lesions that are similar to those in our case [6] . CNS involvements in female patients with X-linked CMT have rarely been reported ( Table 2) . One female case showed upper motor neuron signs (hyper reflexes of the arms, positive Babiniski sign, dysarthria, and wide-based gait) with the development of increased MRI signals in the white matter and atrophy of the distal thoracic cord [12] . Although sequence variants in the GJB1 promoter region were detected in this case, direct DNA sequencing of the GJB1 coding region was normal [12] .
In CMTX, male patients tend to be severely affected, and females are generally asymptomatic. However some heterozygous females carrier have been severely affected [4] . In our case, MNCVs were markedly reduced, below 38 m/s, in the median, tibial and peroneal nerves, suggesting the presence of demyelination. Here we also saw that the CMAP amplitudes were markedly reduced in the median, tibial and peroneal nerves which may suggest axonopathy. Thus, this patient showed both the features of demyelination and axonopathy. GJB1 mutations may induce both axonal and demyelinating features irrespective of the nature and position of the mutation in the GJB1 gene [13] . To date all of the identified Japanese male patients with CMTX were severely affected and showed the features of both demyelination and axonopathy [13] [14] [15] [16] . The degree of neuropathy of our case was as severe as those of these male patients. Previously, a case of sensorineural deafness in a female patient with CMTX was described without any clinical features of motor or sensory deficit [17] . Abnormal brainstem auditory evoked responses have recently been reported in male patients with CMTX neuropathy [18, 19] . Our case did not show such sensorineural deafness or other such associated features, nor did she display any abnormality in central visual or acoustic pathways.
A wide variation in the severity of clinical features was found in carrier females who had later onset of symptoms with some obligate carriers being asymptomatic [20] . But, our case showed early onset of symptoms at the age of 20. The mutation in the extracellular domain of GJB1 may lead to increase chances of CNS involvement [21] .
The R142W substitution is present in the third transmembrane domain of the GJB1 protein which forms a part of the gap junction pore in neuron and might impair or block the channel permeability. Although exert molecular mechanism is still unknown, previously reported mutations on this transmembrane domain may cause increase the frequency of CNS involvement [7, 17] . In the CNS, gap junctions have been identified in neurons ependymal cells astrocytes and oligodendrocytes. Mutation in the transmembrane domain and extracellular domain may also lead to development of CNS lesions. At present, CMTX is thought to be caused by a loss of function mechanism. However, the existence of a female patient with severe clinical symptoms may show that gain of function mechanism also lead to the disorders seen in these patients.
In conclusion, this is the first reported case of a female patient with CMTX who was severely clinically affected, and who showed atypical scattered white matter lesions in the cerebrum. The exact molecular roles played by GJB1 in the peripheral and central nervous systems remain unclear but mutations may cause the central and peripheral nervous system abnormalities found in CMTX, the clinical severity of which is probably related to the types of mutations and their effects on GJB1 function. Table 1 Electrophysiological study 
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